Lars Iversen

Research interests

Publications

• Sand, gravel, and UN Sustainable Development Goals: Conflicts, synergies, and pathways forward

  One Earth · 2021 · 10.1016/j.oneear.2021.07.008

• Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks

  British Journal of Dermatology · 2019 · 10.1111/bjd.18232

• Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30379-6

• Old and New Biological Therapies for Psoriasis

  International Journal of Molecular Sciences · 2017 · 10.3390/ijms18112297

• Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

  Seminars in Immunopathology · 2016 · 10.1007/s00281-016-0594-9

• Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

  British Journal of Dermatology · 2014 · 10.1111/bjd.13551

• Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris

  British Journal of Dermatology · 2014 · 10.1111/bjd.13343

• Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort

  Journal of the European Academy of Dermatology and Venereology · 2014 · 10.1111/jdv.12768

• Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study

  Journal of Internal Medicine · 2012 · 10.1111/j.1365-2796.2012.02593.x

• Detection of a Diverse Marine Fish Fauna Using Environmental DNA from Seawater Samples

  PLoS ONE · 2012 · 10.1371/journal.pone.0041732

• Monitoring endangered freshwater biodiversity using environmental DNA

  Molecular Ecology · 2011 · 10.1111/j.1365-294x.2011.05418.x

• Definition of treatment goals for moderate to severe psoriasis: a European consensus

  Archives of Dermatological Research · 2010 · https://doi.org/10.1007/s00403-010-1080-1

• Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

  British Journal of Dermatology · 2009 · 10.1111/j.1365-2133.2008.08902.x

• The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

  Nature Immunology · 2008 · 10.1038/ni.1644

• Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

  Blood · 2007 · 10.1182/blood-2006-12-062877

• The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin

  British Journal of Dermatology · 2005 · 10.1111/j.1365-2133.2004.06304.x

• Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema

  British Journal of Dermatology · 2005 · 10.1111/j.1365-2133.2005.06415.x

• A survey of occupational hand eczema in Denmark

  Contact Dermatitis · 2004 · 10.1111/j.0105-1873.2004.00423.x

• Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability

  Nature Medicine · 2001 · 10.1038/nm1001-1123

• Modulation of Keratinocyte Gene Expression and Differentiation by PPAR-Selective Ligands and Tetradecylthioacetic Acid

  Journal of Investigative Dermatology · 2001 · https://doi.org/10.1046/j.1523-1747.2001.01329.x

• Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs

  Prostaglandins Leukotrienes and Essential Fatty Acids · 1998 · 10.1016/s0952-3278(98)90125-9

• Unemployment and mortality in Denmark, 1970-80.

  BMJ · 1987 · 10.1136/bmj.295.6603.879

Current projects

No projects listed.